Color
code:
Privately held
Publicly traded (stock ticker symbol)
Acquired, subsidiary, nonprofit, or dissolved
(therefore not counted as a separate genomics firm)
Note: This table is usually updated weekly or biweekly, but is undergoing a major update and will not be revised regularly until sometime in October 2002
Updated 27 August 2002
*Patents in DNA Patent Database (www.genomic.org) through Dec 31, 1999 (in all cases), or when entry updated (see final column).
For listing by public v. private ownership and country of origin (this file updated to 10 June 2001)
| |
Firm Name |
Website |
Public or private? |
Address1 |
Address2 |
City |
State |
PostalCode |
Country |
Phone |
Fax |
PrimaryContact |
|
Founding year |
Firm Type |
Patents* |
Special terms for patent search |
Other Comments |
Date entry modified |
||
|
|
Qiagen Genomics |
Subsidiary of Qiagen |
1725 220th Street SE |
Suite 104 |
Bothell |
WA |
98021 |
|
425-398-3140 |
425-398-3150 |
Andreas Dusterhoft, Director R&D Genomic Services |
6 |
Patents for Qiagen GmbH (parent company) |
||||||||
|
|
PPD Discovery |
Subsidiary of PPD Inc (PPDI) |
1505 B. O’Brien Dr. |
Menlo Park |
CA |
94025 |
|
650.617.2033 |
650.617.9574 |
Fred Eshelman, CEO |
0 |
Susidiary of PPD, Inc. |
|||||||||
|
|
MDS Proteomics Inc |
Subsidiary of MDS Corp. |
75 Internatoinal Boulevard |
Toronto |
M9W6L6 |
|
416-213-4194 or 800-382-4124 |
416-213-4199 |
Ian Lennox, President and CEO of Drug Discovery and Development Sector |
0 |
Subsidiary of MDS Corp; formed new CRO 3/01 |
||||||||||
|
|
Callida Genomics Inc. |
Subsidiary of Hyseq; collaboration with Affymetrix |
George Rathman, Interim President and CEO |
2001 |
INSTRMT, DNASEQ |
Assigned Hyseq sequence-by-hybridization patents; see Hyseq. Owned 90% Hyseq, 10% Affymetrix. |
8aug02 |
||||||||||||||
| 5. |
RNAture |
Subsidiary of Hitachi |
1003 Health Sciences Road West |
Irvine |
CA |
92612-3054 |
|
877-327-8762 949-725-2743 |
949-725-2788 |
Masato Mitsuhashi, President and CEO |
0 |
Wholly owned subsidiary of Hitachi Chemical |
|||||||||
|
|
Expression Analysis |
Subsidiary of Analytical Sciences Inc. |
2605 Meridian Parkway |
Suite 200 |
Durham |
NC |
27713 |
|
(919) 544-8500 |
(919) 544-7507 |
Laura Reid, chief of genomic sciences |
0 |
|||||||||
|
|
Toyobo Tsuruga Gene Analysis Laboratory |
Subsidiary |
10-24, Toyo-cho |
Tsuruga |
914-0047 |
|
81-770-22-7643 |
81-770-22-7671 |
0 |
Genetic testing and contract sequencing; subsidiary of Toyoba |
|||||||||||
|
|
Arradial Inc. |
Started by Alexion, a publicly traded firm |
Boston |
MA |
|
617-241-5794 |
P. Thomas Vogel, President and CEO |
2000 |
0 |
Started by Alexion Pharmaceuticals |
|||||||||||
| 9. |
EXACT Sciences Corp |
Publicly tranded (EXAS) |
63 Great Road |
Maynard |
MA |
01754 |
|
978-897-2800 |
978-897-3481 |
Don M. Hardison, President and CEO |
7 |
10 patents listed as of February 2000; formerly Exact Laboratories, Inc.; IPO Feb 2001 |
|||||||||
|
|
Pharsight Corp. |
Publicly traded; subsidiary NASDAQ: PHST |
11230 Sorrento Valley Road |
Suite 140 |
San Diego |
CA |
02121 |
|
858-625-1343 650-314-3889 Mtn View |
858-597-1353 |
Janice H. Kurth, VP Genomics |
2000 |
0 |
Pharsight mainly a clinical research management firm; genomics branch started 2000 |
|||||||
|
|
LJL Biosystems Inc. |
Publicly traded, now part of Molecular Devices (MDCC) |
404 Tasman Drive |
Sunnyvale |
CA |
94089 |
|
(888)611-4555 |
(408)541-8786 |
Lev Leytes, Chairman, President and CEO |
0 |
Acquired by Molecular Devices Corp. July 2000 |
|||||||||
|
|
CRS Robotics Corp. |
Publicly traded on Toronto SE (ROB) |
5344 John Lucas Drive |
Burlington |
Ontario |
L7L 6A6 |
|
(905) 332-2000 800-365-7587 |
(905) 332-1114 |
Ralph Steedman, President and CEO |
0 |
||||||||||
|
|
Inex Pharmaceuticals |
Publicly traded on Toronto Exchange (IEX) |
100-8900 Glenlyon Parkway |
Glenlyon Business Park |
Burnaby |
BC |
V5J 5J* |
|
604-419-3200 |
604-419-3201 |
David J. Main, President and CEO |
2 |
|||||||||
|
|
Life Technologies Inc. |
Publicly traded on OTC (acquired) |
PO Box 6482 |
Rockville |
MD |
20849-6482 |
|
301-840-8000 |
301-670-1394 |
J. Stark Thompson, President and CEO |
58 |
Being acquired by Invitrogen; deal to be complete in 2000. |
|||||||||
|
|
Genetic Vectors Inc. |
Publicly traded on OTC (GVEC) |
5201 NW 77th Avenue |
Suite 100 |
Miami |
FL |
33166 |
|
305-716-0000 |
305-716-0001 |
Mead McCabe, Jr., CEO |
0 |
Acquired DNA Sciences, Inc (of San Diego, different from DNA Sciences, Inc above) 2/2000 |
||||||||
|
|
GeneScan Europe AG |
Publicly traded on Neuer Market (GEP) |
Engesserstr. 4 b |
79108 |
Freiburg |
|
0761-5038-0 |
0761-5038-111 |
Ulrich Birsner, CEO |
0 |
12 subsidiary companies; no DPD patents for BioChip, GeneScan, or BioRobotics, but refers to a “large patent portfolio at its disposal” and several pending patents on its website. 2000 annual report states 23 patents for 2000, none by 1999. |
||||||||||
|
|
MorphoSys GmbH |
Publicly traded on Neuer exchange (MOR) |
Lena-Christ-Straße 48 |
D- 82152 |
Martinsreid/Munich |
|
49 (0)89 89927 0 |
49 (0)89 89927 222 |
Simon E. Moroney, CEO |
1 |
|||||||||||
|
|
Oxford GlycoSciences plc |
Publicly traded on London Exchange (OGSI; OGS) |
2 The Quadrant, Barton Lane |
Abingdon Science Park |
Abingdon |
Oxon |
OX16 3J |
|
(44)1235-543200 |
(44)1235-554701 |
David Ebsworth, CEO |
5 |
(Patents for Oxford gene systems =3, Oxford technologies 1, Oxford biomedica 1; See also ISIS Innovation with 7 patents) |
||||||||
|
|
Pharmagene PLC |
Publicly traded on London Exchange (PGN) |
Orchard Road |
Royston |
Hertfordshire |
SG8 5HD |
|
44 0-1763 211 600 |
44-1-1763-211 630 |
Alastair Riddell, CEO |
0 |
IPO 7/2000 |
|||||||||
|
|
Molecular Devices Corp. |
Publicly traded NASDAQ: (MDCC) |
1311 Orleans Drive |
Sunnyvale |
CA |
94089 |
|
800-635-5577 |
Joseph D. Keegan, President and CEO |
2000 |
0 |
Merger of LJL BioSystems July 2000 |
|||||||||
|
|
Zymogenetics |
Publicly traded (ZGEN) |
1201 Eastlake Avenue East |
Seattle |
WA |
98102-3702 |
|
206-442-6600 |
206-442-6608 |
Bruce L. A. Carter, President and CEO |
80 |
Established as US discovery arm of Novo Nordisk;separate company 2000, IPO Feb 2002 |
|||||||||
|
|
Valentis Inc. |
Publicly traded (VLTS) |
863A Mitten Road |
Burlingame |
CA |
94010 |
|
650.697.1900 |
650.652.1990 |
Banjamin F. McGraw, President and CEO |
Ben@valentis.com CEO |
4 |
Website lists 58 Issued US patents 2/15/01 |
Formed from merger of PolyMASC, GeneMedicine, and Megabios |
|||||||
|
|
Sigma Genysys |
Publicly traded (subsidiary, not included in R&D or market cap figures) |
1442 Lake Front Circle |
The Woodlands |
TX |
77380 |
|
800-234-5DNA |
281-363-2693 |
0 |
Subsidiary of Sigma Aldrich {not included among publicly traded genomics firms due to small fraction of genomics business) |
||||||||||
|
|
Sangamo Biosciences Inc. |
Publicly traded (SGMO) |
501 Canal Boulevard |
Richmond |
CA |
94804 |
|
510-970-6000 |
510-236-8951 |
Edward O. Lanphier, President and CEO |
0 |
Acquired Gendaq June 2001 |
|||||||||
|
|
Rosetta Inpharmatics |
Publicly traded (RSTA). Acquired by Merck (not included in figures and tables) |
12040-115th Avenue NE |
Kirkland |
WA |
98034 |
|
425-820-8900 |
425-821-5354 |
Stephen Friend, President and CSO |
1 |
IPO August 8, 2000; Acquisition by Merck & Co. announced May 11, 2001. |
|||||||||
|
|
Paradigm Genetics |
Publicly traded (PDGM) |
104 Alexander Drive, Building 2 |
PO Box 14528 |
Research Triangle Park |
NC |
27709-4528 |
|
919-425-3000 |
919-544-8094 |
Heinrich Gugger, President and CEO |
1997 |
GENEFNL, GENEXPR, AGRIVET |
2 |
27jul02 |
||||||
| 27. |
Pharmacopeia |
Publicly traded (PCOP) |
3000 Eastpark Boulevard |
Cranbury |
NJ |
08512 |
|
609 452 3600 |
609 452 3672 |
Joseph A. Mollica, President and CEO |
4 |
Owns Accelrys, which acquired Synomics June 2001; acquired Eos Aug 2001. |
|||||||||
|
|
Genetix |
Publicly traded (GTX.L) on FTSE |
Queensway |
New Milton |
Hampshire |
BH25 5NN |
|
01-425-624-600 |
01-425-624700 |
Mark Reid, CEO |
0 |
Acquired Genpak Ltd. IPO November 2000 |
|||||||||
|
|
Ecopia Biosciences Inc. |
Publicly traded (EIA TorontoSE) |
7290 Frederick-Banting |
Saint-Laurent |
Québec |
|
(514) 336-2700 |
(514) 336-8827 |
Eric A. Cohen, Chairman and CEO |
0 |
|||||||||||
| 30. |
Epoch Biosciences |
Publicly traded (EBIO) |
21720 - 23rd Dr. SE |
Suite 150 |
Bothell |
WA |
98021 |
|
425.482.5555 |
425.482.5550 |
Bill Gerber, CEO |
10 |
Includes patents for Epoch Pharmaceuticals, Bothell and Redmond, WA |
||||||||
| 31. |
AVI BioPharma |
Publicly traded (AVII; AVIIW; AVIIZ) |
One SW Columbia Street |
Suite 1105 |
Portland |
OR |
97258 |
|
503-227-0554 |
503-227-0751 |
Denis R. Burger, CEO |
1 |
Assigned to AntiVirals Inc. (former name) Also licensed 11 patents from Ohio State Univ, 16 from Univ Nebraska |
||||||||
|
|
Autogen Limited |
Publicly traded (ATG Australian Stock Exchange) |
210 Kings Way |
South Melbourne |
Victoria |
3205 |
|
61 3 9234 1188 03 9234 1188 or 0419 897 501 |
61 3 9234 1198 |
Greg Collier, Chief Scientific Officer |
0 |
||||||||||
|
|
Array BioPharma |
Publicly traded (ARRY) |
1885 33rd Street |
Boulder |
CO |
80301 |
|
303-381-6600 |
303-449-5376 |
Robert E. Conway, CEO |
0 |
IPO Nov 2000 |
|||||||||
|
|
Genetic Technologies Ltd. |
Publicly traded (GTG ASX) |
60-66 Hanover Street |
Fitzfory |
Victoria |
3065 |
|
3.9415.1135 |
3.9417.2987 |
Mervyn Jacobson, Executive Chairman |
5 |
Acquired
GeneType AG (Zug, |
|||||||||
| 35. |
Chondrogene Inc. |
Publicly traded (YDG on Canadian Venture Exchange) |
800 Petrolia Road |
Unit No. 15 |
Toronto |
Ontario |
|
(416) 650-0060 |
(416) 650-0055 |
David E Caspari, President and CEO |
0 |
||||||||||
|
|
Genomics One Corporation |
Publicly traded on Montreal Eschange (GNX) |
3030 Le Carrefour Blvd. |
Suite 902 |
Laval |
Quebec |
H7T 2P5 |
|
(877)684-3637 (450)688-4499 |
Dr. Suzanne Lebel, President |
0 |
||||||||||
|
|
SignalGene Inc. |
Publicly traded (SGI) |
8475 Christophe-Colomb Avenue |
Suite 1000 |
Montreal |
Quebec |
H2M 2N9 |
|
(514)850-2400 |
(514)850-2424 |
George Masters, Interim President and CEO |
0 |
|||||||||
|
|
Tm Bioscience Corp. |
Publicly traded (CDNX: TMC) |
439 University Ave. |
11th Floor |
Toronto |
Ontario |
|
(416) 593-4323 |
(416) 593-1066 |
Gregory C. Hines, President & CEO |
0 |
||||||||||
| 39. |
Azign Bioscience A/S |
Publicly traded NeuroSearch AS (NEUS.CO) |
Vestre Teglgade 10 |
Copenhagen |
DK-2450 |
|
45 70 22 22 02 |
45 70 23 23 04 |
0 |
Formed with merger of NeuroSearch AS acquisition of Display Systems Biotech AS |
|||||||||||
|
|
LION BioScience AG |
Publicly traded ( |
Im Neuenheimer Feld 517 |
Heidelberg |
D 69120 |
|
49-6221-403-823 |
49-6221-403-835 |
Friedrich von Bohlen, CEO |
0 |
IPO July 10, 2000 |
||||||||||
|
|
deCODE Genetics |
Publicly traded (DCGN) |
Lynghalsi 1 |
Rekjavik |
IS-100 |
|
354-577-1900 |
354-577-1901 |
Kari Stefansson, President and CEO |
0 |
MediChem also |
IPO July 2000; acquired MediChem March 2002 |
|||||||||
|
|
Keryx Biopharmaceuticals Inc. |
Publicly traded (KERX) |
Kiryat Mada 5 |
Har Hotzvim |
Jerusalem |
91326 |
|
972-2-541-2700 |
972-2-541-2701 |
Morris Laster, CEO |
0 |
IPO June 2000 |
|||||||||
|
|
Biacore AB |
Publicly traded (BCOR) |
Radsgatan |
SE-754 50 |
Uppsala |
|
46 18 675700 |
46 18 150110 |
Ulf Jonsson, President |
2 |
|||||||||||
|
|
Pyrosequencing AB |
Publicly traded (PYRO A: Stockholm) |
SE-752 |
Uppsala |
28 |
|
46-18-565-900 |
46-18-516000 |
Erik Wallden, President and CEO |
0 |
|||||||||||
|
|
Cytomyx |
Publicly traded (EPIC-CYX) on AIM |
140 Science Park |
Cambridge |
CB4 0GF |
|
44-1223-508191 |
44-1223-508198 |
0 |
Formerly Cambridge BioScience |
|||||||||||
|
|
Gemini Genomics Ltd. |
Publicly traded (GMNI) being acquired by Sequenom |
162 Science Park |
Cambridge |
CB4 0GH |
|
44-0-1223-435300 44 1223 435339 |
44-0-1223-435301 |
Paul Kelly, CEO |
2 |
IPO July 2000; announced acquisition by Sequenom May 2001 completed Q3 2001. |
||||||||||
|
|
Abgenix |
Publicly traded (ABGX) |
7601 Dumbarton Circle |
Fremont |
CA |
94555 |
|
(510)608-6500 |
(510)608-6589 |
R. Scott Greer, Chairman, President and CEO; Raymond Withy to become CEO mid-2002 |
4 |
||||||||||
|
|
Aclara Biosciences Inc. |
Publicly traded (ACLA) |
1288 Pear Avenue |
Mountain View |
CA |
94034 |
|
650-210-1200 |
Joseph M. Limber, President and CEO |
0 |
|||||||||||
|
|
Affymetrix Inc. |
Publicly traded (AFFX) |
3380 Central Expressway |
Santa Clara |
CA |
95051 |
|
(408)731-5000 |
(408)481-0422 |
Stephen Fodor, CEO |
25 |
||||||||||
|
|
Applied Biosystems |
Publicly traded (ABI) |
850 Lincoln Centre Drive |
Foster City |
CA |
94404 |
|
650-638-5800 800-345-5224 |
650-638-5884 |
Michael Hunkapiller, President |
27 |
Includes PerSeptive Biosystems patents (4);, Boston Probes; PNA Diagnostics |
Name reverted to Applied Biosystems July 2000 (was PE Biosystems 1997-2000) |
||||||||
|
|
Applied Molecular Evolution Inc. |
Publicly traded (AMEV) |
3520 Dunhill Street |
San Diego |
CA |
92121 |
|
858-597-4990 |
858-597-4950 |
William D. Huse |
6 |
Formerly Ixsys (includes Ixsys patents) |
IPO July 2000 |
||||||||
|
|
ARIAD Pharmaceuticals Inc. |
Publicly traded (ARIA) |
26 Landsdowne Street |
Cambridge |
MA |
02139 |
|
(617)494-0400 |
(617)494-8144 |
Harvey J. Berger, Chairman and CEO |
1 |
||||||||||
|
|
Aurora Biosciences Corp. |
Publicly traded (ABSC). Acquired by Vertex. |
11010 Torreyana Road |
San Diego |
CA |
92121 |
|
(619)404-6600 |
(619)404-6714 |
Michael Wokasch, President, Chairman, and CEO |
5 |
3 for Aurora; 2 for PanVera, which was acquired by Aurora in Feb 2001 |
Aurora acquired by Vertex July 2001 |
||||||||
|
|
AxyS Pharmaceuticals Inc. |
Publicly traded (AXPH). Acquired by Celera. |
180 Kimball Way |
South San Francisco |
CA |
94080 |
|
(650)829-1000 |
(650)829-1001 |
John P. Walker, Chairman and CEO |
5 |
(Patents include Sequana [former name for Axyxs]). |
Celera announced acquisition of Axys 13 June 2001; approved Nov 2001. |
||||||||
|
|
Bruker Daltonics |
Publicly traded (BDAL) |
15 Fortune Drive |
Billerica |
MA |
01821 |
|
978-663-3660 |
978-667-5993 |
Frank H. Laukien, President and CEO |
2 |
Patents
assigned to parent company in |
|||||||||
|
|
Caliper Techologies Corp. |
Publicly traded (CALP) |
605 Fairchild Drive |
Mountain View |
CA |
94043-2324 |
|
650-623-0700 |
650-623-0500 |
Daniel L. Kisner, CEO and President |
3 |
1999 annual report states the company owns 52 patents (DPD count to left contains only DNA-based patents). Most Caliper patents are in microfluidics |
|||||||||
|
|
Celera Genomics |
Publicly traded (CRA) |
45 West Gude Drive |
Rockville |
MD |
20850 |
|
(877)CELERA1 240-453-3000 |
(240)453-4000 |
Kathy Ordoñez, President |
5 |
Celera had no patents, but acquired Axys (formerly Sequana) in June 2001. (Patents for Perken-Elmer, Applied Biosystems, PerSeptive Biosystems or PE Corp. = 63) |
|||||||||
|
|
Cepheid |
Publicly traded (CPHD) |
1190 Borregas Avenue |
Sunnyvale |
CA |
94089-1302 |
|
408-541-4191 |
408-541-4192 |
John L. Bishop, CEO |
0 |
||||||||||
|
|
Ciphergen Biosystems |
Publicly traded (CIPH) |
6611 Dumbarton Circle |
Freemont |
CA |
94555 |
|
510-505-2100 |
510-505-2101 |
William E. Rich, President and CEO |
0 |
IPO Sept 2000 |
|||||||||
|
|
Corixa |
Publicly traded (CRXA) |
1124 Columbia Street |
Suite 200 |
Seattle |
WA |
98104-2040 |
|
206-754-5711 |
206-754-5715 |
Steven Gillis, Chairman and CEO |
4 |
|||||||||
|
|
CuraGen Corp. |
Publicly traded (CRGN) |
555 Long Wharf Drive |
11th floor |
New Haven |
CT |
06511 |
|
(888)GENOMICS |
203-401-3331 |
Jonathan M. Rothberg, CEO |
3 |
|||||||||
|
|
Deltagen |
Publicly traded (DGEN) |
1003 Hamilton Court |
Menlo Park |
CA |
94025 |
|
650-752-0200 650-752-0208 |
650-752-0202 |
William Matthews, CEO Michael Sember, President and COO |
4 |
IPO Aug 2000; Acquired Arcaris (and its 4 DPD patents) July 2001. |
|||||||||
|
|
Digene Inc |
Publicly traded (DIGE); to be acquired by Cytyc |
1201 Clopper Road |
Gaithersburg |
MD |
20878 |
|
800-344-3631 301-944-7000 |
301-944-7121 |
Evan Jones, President and CEO |
7 |
5 patents through 1999; 2 patents 2000; Cytyc to purchase Digene, April 2002 |
|||||||||
| 64. |
Discovery Partners International |
Publicly traded (DPII) |
9640 Towne Centre Drive |
San Diego |
CA |
92121 |
|
858-455-8600 |
858-546-3081 |
Ricardo Pigliucci, President and CEO |
Email via website |
3 |
|||||||||
|
|
Diversa Corp. |
Publicly traded (DVSA) |
10665 Sorrento Valley Road |
San Diego |
CA |
92121 |
|
619-453-7020 |
619-453-7032 |
Terrance Bruggamen, Chairman and CEO |
20 |
||||||||||
|
|
DNAPrint Genomics |
Publicly traded |
900 Cocoanut Avenue |
Sarasota |
FL |
34236 |
|
941-366-3400 |
941-952-9770 |
Anthony Frudakis, CEO and President |
2000 |
DNATest, dnaseqn, infrmtx |
0 |
Does not have patents assigned to the firm; website lists 8 patent applications and notes the the President and CEO holds 7 patents that cover 350 genes and 2 products |
Was acquired by previously bankrupt CYTC; Catalyst Communications and began gene testing |
27aug02 |
|||||
|
|
Exelixis Pharmaceuticals Inc. |
Publicly traded (EXEL) |
260 Littlefiled Ave. |
South San Francisco |
CA |
94080 |
|
650-825-2200 |
650-825-2205 |
George Scangos, President and CEO |
0 |
Website notes 2 patents, but not contained in DPD through Dec ’99; announced acquisition of Genomica Corp. Nov 2001. |
|||||||||
| 68. |
Genaera |
Publicly traded (GENR) |
5110 Campus Drive |
Plymouth Meeting |
PA |
19462 |
|
(610) 941-4020 |
(610) 941-5399 |
Roy C. Levitt, President and CEO |
Info@genaera.com |
4 |
Former name Magainin (to which name patents are assigned) |
Formerly Magainin |
|||||||
|
|
Genaissance Pharmaceuticals Inc. |
Publicly traded (GNSC) |
5 Science Park |
New Haven |
CT |
06511 |
|
203-773-1450 |
203-562-9377 |
Gualberto Ruano, CEO and President |
1 |
||||||||||
|
|
Gene Logic Inc. |
Publicly traded (GLGC) |
708 Quince Orchard Road |
Gaithersburg |
MD |
20878 |
|
(301)987-1700 |
(301)987-1701 |
Mark D. Gessler, President and COO |
3 |
(Patents include Oncormed, purchased 12/98) |
|||||||||
|
|
GeneLink Inc. |
Publicly traded (GNLK) |
PO Box 3212 |
Margate |
NJ |
08402 |
|
800.558.4363 609-823-6991 |
John R. DePhillipo, President and CEO |
0 |
Website notes new patent 6,291,171 (25 Oct 2000) not in DPD; two other patents pending as of Jan 2002. |
||||||||||
|
|
Genome Therapeutics Corp. |
www.cric.com or |
Publicly traded (GENE) |
100 Beaver Street |
Waltham |
MA |
02453-8443 |
|
(781)398-2300 |
(781)893-9535 or -8277 |
Robert J. Hennessey, President, Chairman, and CEO; Bernard Seizinger, CSO |
8 |
Patents include from Collaborative Research Labs |
||||||||
|
|
Genomica Corporation |
Publicly traded (GNOM); acquired by Exelixis |
4001 Discovery Drive |
Suite 130 |
Boulder |
CO |
80303 |
|
(303)402-9800 |
(303)402-9877 |
James Clemens, VP of Development |
0 |
IPO 28 Sept 2000; acquisition by by Exelixis announced Nov 2001 |
||||||||
|
|
Global Genomics Inc. |
Publicly traded (CYTR) |
11726 San Vicente Blvd. |
Suite 650 |
Los Angeles |
CA |
90049 |
|
310.826.5648 |
310.826.6139 |
Steven A Kriegsman, President and CEO |
2002 |
GENEFNL, AGRIVET, TRSTFND, DRUGDEV |
0 |
CytRx and Global Genomics Capital |
Formed from May 2002 merger of CytRx and Global Genomics Capita; owns 40% of Blizzard Genomics and 5% of Psynomicsl |
27jul02 |
||||
|
|
Harvard Biosciences |
Publicly traded (HBIO) |
84 October Hill Road |
Holliston |
MA |
01746 |
|
508.893-8999 800.272.2775 |
508.429.5732 |
Chane Graziano, CEO |
1901; entered genomics 2002 |
INSTRMT, SUPPLYR |
1 |
Genome Solutions patent |
Acquired Genomic Solutions July 2002 |
27jul02 |
|||||
|
|
Human Genome Sciences Inc. |
Publicly traded (HGSI) |
9410 Key West Avenue |
Rockville |
MD |
20850 |
|
(301)309-8504 |
(301)309-8512 |
William Haseltine, President |
106 |
(128 patents through 6/12/2000) |
|||||||||
|
|
Hyseq Inc. |
Publicly traded (HYSQ) |
675 Almanor Avenue |
Sunnyvale |
CA |
94086 |
|
(408)524-8100 |
(408)524-8117 |
Ted. W. Love, CEO |
1992 |
INSTRMT, DNASEQ |
14 |
Callida and N-Mer are subsidiaries. |
8aug02 |
||||||
|
|
Illumina Inc. |
Publicly traded (ILMN) |
9390 Towne Centre Drive |
Suite 200 |
San Diego |
CA |
92121 |
|
(858) 587-4290 (858)587-4233 |
(858) 587-4297 |
Jay Flatley, President and CEO |
1998 |
INSTRMT, GENEXPR, SUPPLYR |
0 |
27jul02 |
||||||
|
|
Incyte Genomics Inc. |
Publicly traded (INCY) |
3160 Porter Drive |
Palo Alto |
CA |
94304-1203 |
|
(650)855-0555 |
(650)855-0572 |
Paul A. Friedman, CEO |
276 |
(474 patents through 6/12/2000) |
|||||||||
|
|
InforMax Inc. |
Publicly traded (INMX) |
6010 Executive Boulevard |
10th floor |
North Bethesda |
MD |
20852 |
|
240-223-0100 301-984-2206 |
240-223-3201 |
Andrew Whiteley, President, Chairman, and CEO |
0 |
IPO 28 Sept 2000 |
||||||||
|
|
Insightful Inc. |
Publicly traded (IFUL) |
1700 Westlake North |
Suite 500 |
Seattle |
WA |
98109-3044 |
|
206.283.8802 |
Shawn Javid, President and CEO |
0 |
Data mining (genomics only small part of business); NIH SBIR award July 2002; R&D figures reported p. 22 of 2001 annual report (‘news’ on website) |
|||||||||
|
|
Invitrogen Inc. |
Publicly traded (IVGN) |
1600 Faraday Avenue |
Carlsbad |
CA |
92008 |
|
800-955-6288 |
760-603-7201 |
Lyle C. Turner, Chairman and CEO |
2 |
Purchasing Life Technologies; deal to close by end of 2000. |
|||||||||
|
|
Large Scale Biology (and Proteomics) |
Publicly traded (LSBC) |
3333 Vaca Valley Pkwy |
Suite 1000 |
Vacaville |
CA |
95688 |
|
707-446-5501 |
707-446-3917 |
Robert L. Erwin, President and CEO |
17 |
BioSource Technologies purchased and changed names to Large Scale Biology 1999 (count includes both Cos.); IPO Aug 2000 |
||||||||
|
|
Lexicon Genetics Incorporated |
www.lexicon-genetics.com see also |
Publicly traded (LEXG) |
4000 Research Forest Drive |
The Woodlands |
TX |
77381-4287 |
|
(281)364-0100 |
(281)364-0155 |
Arthur Sands, President and CEO |
0 |
Knockout mouse initiative through Merck Genome Research Institute |
||||||||
|
|
Lynx Therapeutics Inc. |
Publicly traded (LYNX) |
25861 Industrial Blvd. |
Hayward |
CA |
94545 |
|
(510)670-9300 |
(510)670-9302 |
Kevin Corcoran, President and CEO |
27 |
||||||||||
|
|
Magainin Pharmaceuticals Inc. |
Publicly traded (MAGN). Name changed (don’t include in tables and figures) |
5110 Campus Drive |
Plymouth Meeting |
PA |
19462 |
|
610-941-4020 |
(610) 941-5399 |
Michael R. Dougherty, President and CEO |
4 |
Name changed to Genaera (see above) |
|||||||||
|
|
Maxygen Inc. |
Publicly traded (MAXY) |
515 Galveston Drive |
Redwood City |
CA |
94063 |
|
650-298-5300 |
650-364-2715 |
William P. C. Stemmer, Vice President for Research |
1 |
||||||||||
|
|
Millennium Pharmaceuticals Inc. |
Publicly traded (MLNM) |
75 Sidney Street |
Cambridge |
MA |
02139 |
|
(617)679-7000 617-679-7219 CEO |
(617)374-9379 |
##Steven H. Holtzman, Chief Business Officer |
161 |
(Includespatents for “Millenium” and “Milennium” misspelled) |
|||||||||
|
|
Myriad Genetics Inc. |
Publicly traded (MYGN) |
320 Wakara Way |
Salt Lake City |
UT |
84108 |
|
(801)584-3600 |
(801)584-3640 |
Mark Skolnick, CSO |
16 |
||||||||||
|
|
Onyx Pharmaceuticals Inc. |
Publicly traded (ONXX) |
3031 Research Drive |
Richmond |
CA |
94806 |
|
(510)222-9700 |
(510)222-9758 |
Allan Balmain, VP for Research |
13 |
||||||||||
|
|
Orchid BioSciences Inc. |
Publicly traded (ORCH) |
303 College Road East |
Princeton |
NJ |
08540 |
|
609-750-2200 |
609-750-2250 |
Dale Pfost, President an CEO |
11 |
Started as Orchid Biocomputers Inc.; Acquired LifeCodes Oct 2001 (4 Orchid patents, 7 Lifecodes patents). |
|||||||||
|
|
OSI Pharmaceuticals |
Publicly traded (OSIP) |
777 Old Saw Mill River Road |
Tarrytown |
NY |
10591-6705 |
|
914-467-6200 ext 314 CEO; (Corp HQ in Uniondale 516-222-0023) |
516-222-0114 |
Benjamin Benton, Head of Functional Genomics |
0 |
||||||||||
|
|
Packard Bioscience |
Publicly traded (PBSC) |
800 Research Parkway |
Meriden |
CT |
06450 |
|
203-238-2351 800-243-4422 201-329-8660 |
Emery G. Olcott, CEO |
1 |
|||||||||||
|
|
Pathogenesis Corp.. |
Publicly traded (PGNS) |
201 Elliott Avenue West |
Seattle |
WA |
98119 |
|
206-467-8100 |
206-270-313 |
Wilbur H. Gantz, Chairman and CEO |
3 |
||||||||||
|
|
Protein Design Labs |
Publicly traded (PDLI) |
34801 Campus Drive |
Fremont |
CA |
94555-3606 |
|
(650)903-3700 |
(650)903-3730 |
Douglas O. Ebersole, Interim CEO |
7 |
||||||||||
|
|
Rigel Inc. |
Publicly traded (RIGL) |
240 E. Grand Avenue |
South San Francisco |
CA |
94080 |
|
650-624-1100 |
650-624-1101 |
James Gower, President and CEO |
0 |
IPO 11/28/00 |
|||||||||
|
|
Seattle Genetics Inc. |
Publicly traded (SGEN) |
22215 26th Avenue SE |
Suite 3000 |
Bothell |
WA |
98021 |
|
425-489-4990 |
425-489-4798 |
H. Perry Fell, CEO |
0 |
Licenses to patents from CEO and CSO |
IPO Mar 2001 |
|||||||
|
|
Sequenom Inc. |
Publicly traded (SQNM) |
11555 Sorrento Valley Road |
San Diego |
CA |
92121-1331 |
|
858-350-0345 |
858-350-0344 |
Hubert Koster, President and CEO |
8 |
6 Sequenom + 2 Gemini Genomics; announced acquisition of Gemini May 2001. Total of 11 issued gene patents and 89 pending; 59 issued or allowed technology patents with 96 pending between the two companies as of May 2001. |
|||||||||
|
|
Targeted Genetics Corp. |
Publicly traded (TGEN) |
1100 Olive Way |
Suite 100 |
Seattle |
WA |
98101 |
|
206-623-7612 |
206-623-0288 |
H. Stewart Parker, President and CEO |
3 |
|||||||||
|
|
Third Wave Technologies Inc. |
Publicly traded (TWTI) |
502 South Rosa Road |
Madison |
WI |
53719 |
|
888-898-2357 608-273-8933 |
608-273-8618 |
Lance Fors, CEO |
12 |
Plan for acquisition by PE Biosystems announced 1/24/2000. Merger canceled 5/2000. IPO announced, delayed; occurred Feb 2001. |
|||||||||
|
|
Transgenomic Inc. |
Publicly traded (TBIO) |
12325 Emmet Street |
Omaha |
NE |
68164 |
|
(888)233-9283 |
(402)452-5453 |
Collin D'Silva, CEO |
16 |
Services Co., IPO 7/2000 |
|||||||||
|
|
Tripos |
Publicly traded (TRPS) |
1699 South Hanley Road |
Saint Louis |
MO |
63144-2913 |
|
314-647-1099 or 800-323-2960 |
314-6479241 |
John P. McAlister III, President and CEO |
0 |
||||||||||
|
|
Variagenics Inc. |
Publicly traded (VGNX) |
60 Hampshire Street |
Cambridge |
MA |
02139-1562 |
|
617-588-5300 |
617-588-5399 |
Jay Mohr, President and CBO |
0 |
Pharmacogenetics, IPO 7/2000 |
|||||||||
|
|
Vysis Inc. |
Publicly traded (VYSI). Acquired by Abbott. |
3100 Woodcreek Drive |
Downers Grove |
IL |
60515-5400 |
|
(800)553-7042 |
(630)271-7138 |
John L. Bishop, President and CEO |
4 |
Acquired by Abbott Nov 2001. |
|||||||||
|
|
Xenometrix |
Publicly traded OTCBB:XENO.OB |
2425 North 55th Street |
Boulder |
CO |
80301-5700 |
|
303-447-1773 |
303-447-1758 |
Pauline Gee, President and CEO |
1 |
Quarterly 10QSB SEC of 2/14/01 also notes EPO patent and “similar patents” but does not further specify them. |
Acquired by Discovery Partners Feb 2001 (NASDAQ: DPII) |
||||||||
|
|
Cereon Genomics LLC |
Privately held. Subsidiary shut down by Monsanto. |
45 Sidney Street |
Cambridge |
MA |
02139 |
|
617-551-8000 |
617-551-1990 |
David Fischhoff & Mark Trusheim, co-Presidents |
0 |
Subsidiary of Pharmacia, formed in partnership betw. Monsanto and Millennium; agricultural genomics. Shut down by Monsanto April 2002. |
|||||||||
| 107. |
CombiMatrix Inc. |
Privately held. Plan for IPO. |
6500 Harbor Heights Parkway |
Mukilteo |
WA |
98275 |
|
425.493.2000 |
425.493.2010 |
Amit Kumar, President and CEO |
1995 |
Instrmt, genetest |
0 |
IPO registration filed Nov 2000; plan to float stock separate from majority owner, Acacia, proposed March 2002; no IPO as of Aug 2002. |
27aug02 |
||||||
|
|
Scriptgen Pharmaceuticals Inc. |
Privately held. Merged to become Anadys. |
610 Lincoln Street |
Waltham |
MA |
02451-2186 |
|
781-768-3400 |
781-768-0040 |
Mark Weedon, President and CEO |
1 |
Merged with Asklepios to form Anadys (see above). |
|||||||||
|
|
Genometrix Inc. |
Privately held. Ceased operations. Patent rights acquired by High Throughput Genomics. |
2700 Research Forest Drive |
Suite B7 |
Woodlands |
TX |
77381 |
|
281-465-5000 |
281-465-5002 |
Robert Ellis, CEO (moved to Affymetrix just before Genometrix ceased operations) |
(0) |
IPO registerd and withdrawn Spring 2001; ceased operations 25 June 2001; Universal Array patent rights purchased by High Throughput Genomics Feb 2002 |
27aug02 |
|||||||
| 110. |
Prospect Genomics Inc. |
Privately held. Acquired by Structural GenomiX |
2618 Belmont Canyon Road |
Belmont |
CA |
94002 |
|
650-654-3510 |
650-996-2095 |
Richard D. Goold, President |
0 |
Acquired by Structural GenomiX, April 2001 |
|||||||||
|
|
NetGenics Inc. |
Privately held. Acquired by LION |
1717 E. Ninth Street |
Suite 1600 |
Cleveland |
OH |
44114 |
|
216-861-4007 888-861-9007 |
216-861-4777 |
Manuel J. Glynias, President and CEO |
0 |
IPO registered Mar 2000, but put on hold; acquired by LION BioScience Jan 2002 |
||||||||
|
|
Mitotix Inc. |
www.mitotix.com redirects to: www.gpc-biotech.com |
Privately held. Acquired by GPC Biotech |
Building 600 |
Suite 622, One Kendall Square |
Cambridge |
MA |
02139 |
|
617-225-0001 |
617-225-0005 |
William Helman, Chairman |
8 |
Purchased by GPC Biotech |
|||||||
|
|
Genomic Medicine Inc. |
Privately held. Acquired by GenoMed |
Saint Louis |
MO |
|
Letter of intent to acquire from GenoMed Nov 2001. |
|||||||||||||||
|
|
Advanced Array Technology SA |
Privately held. Acquired by Eppendorf. |
rue de Seminaire, 22 |
B-5000 |
Namur |
|
32-81-724151 |
32-81-725128 |
Jose Remacle, Director of Biochemistry and Cellular Biology |
1999 |
INSTRMTN, SUPPLYR |
0 |
Univ Namur spinoff; majority acquired by Eppendorf July 2002 |
27jul02 |
|||||||
|
|
Arcaris Inc. |
Privately held. Acquired by Deltagen. |
615 Arapeen Drive |
Suite 300 |
Salt Lake City |
UT |
84108 |
|
801-303-0300 |
M. Scott Salka, CEO |
2 |
Acquired by Deltagen July 2001 |
|||||||||
|
|
Boston Probes |
Privately held. Acquired by Applied Biosytems. |
75E Wiggins Ave. |
Bedford |
MA |
01730 |
|
781-271-1100 |
781-276-4931 |
Jack T. Johansen, CEO |
1 |
Acquired by Applied Biosystems, Nov 2001 |
|||||||||
|
|
Neomorphic Inc. |
Privately held. Acquired by Affymetrix. |
2612 8th Street |
Berkeley |
CA |
|
510-704-1030 |
(510) 704-1013 |
Cyrus Harmon, President and CEO |
0 |
Acquired by Affymetrix Oct 2000 |
||||||||||
|
|
Shanghai Genecore BioTechnologies Co. Ltd. |
Privately held. Subsidiary of Applera. |
Thrid Floor |
No. 200 |
Tian Lin Road |
Shanghai |
|
021-64956278 |
021-64859746 |
0 |
Wholly foreign-owned subsidiary of Applera and Celera Corps. |
||||||||||
|
|
Structural Bioinformatics Inc |
Privately held. SBI subsidiary. |
10929 Technology Place |
San Diego |
CA |
92127 |
|
858-675-2400 |
858-451-3828 |
Edward T. Maggio, President and CEO |
0 |
Subsidiary of SBI Advanced Technologies A/S |
|||||||||
|
|
DoubleTwist Inc. |
Privately held. Ceased operations. |
2001 Broadway |
Oakland |
CA |
94612 |
|
510-628-0100 |
510-628-0108 |
Robert Williamson, President and CEO |
0 |
Includes Pangea (former name); ceased operations March 2002 |
|||||||||
|
|
GenomicFX |
Privately held. Ceased operations. |
12024 Vista Parke Drive |
Suite 2250 |
Austin |
TX |
78726 |
|
512-439-5300 |
512-439-5275 |
Announced it would cease operations Aug 2001. Had acquired Genetic Solutions of Brisbane, Australia (not Genomic Solutions, listed below). |
||||||||||
|
|
Gendaq |
Privately held. Acquired by Sangamo. |
1-3 Burtonhole Lane |
London |
NW7 1AD |
|
44-20-8982-6738 |
44-20-8982-6748 |
Timothy Brears, CEO |
0 |
Acquisition by Sangamo Biosciences announced 29 June 2001 |
||||||||||
|
|
Paracel |
Privately held. Acquired by Celera. |
80 S. Lake Ave |
Suite 650 |
Pasadena |
CA |
91101-2616 |
|
626-744-2000 626-744-2188 CEO |
626-744-2001 |
Shi-Ping Hsu, VP Technology and Business Development |
0 |
(Purchased by Celera June 2000) |
||||||||
|
|
Artemis Pharmaceuticals GmbH |
Privately held (to be acquired by Exelixis) |
Neurather Ring 1 |
D-51063 |
Koln |
|
49-0-221-964530 |
49-0-221-9645321 |
Peter Stadler, CEO |
0 |
Acquired by Exelexis Pharmaceuticals Inc. |
||||||||||
|
|
Rapigene Inc. |
Privately held (subsidiary) |
1725 220th Street SE |
Suite 200 |
Bothell |
WA |
98021 |
|
425-398-3100 |
425-398-3150 |
Nick McCooke, President and COO |
1 |
Owned by Qiagen |
||||||||
|
|
GenoSpectra Inc. |
Privately held |
6519 Dumbarton Circle |
Suite 506 |
Fremont |
CA |
94555 |
(510) 818-2600 |
510.818.2610 |
Frank Witney, CEO Anthony C. Chen, President |
2000 |
GENEFNL, INSTRMT, SUPPLYR |
0 |
30jul02 |
|||||||
|
|
PsychoGenics Inc. |
Privately held |
4 Skyline Drive |
Hawthorne |
NY |
10532 |
(914) 593-0640 |
(914) 593-0645 |
Emer Leahy, President and CEO |
0 |
|||||||||||
|
|
Bresagen |
Privately held |
PO Box 259 |
Rundle Mall |
Adelaide |
5000 |
|
61-8-8234-2660 |
61-8-8234-6268 |
John Smeaton, Managing Director |
0 |
||||||||||
|
|
Exgenix |
Privately held |
576 Swan Street |
Richmond |
Victoria |
3121 |
|
61-3-9208-4444 |
0 |
||||||||||||
|
|
Proteome Systems Ltd |
Privately held |
Locked Bag 2073 |
North Ryde, 1670 |
NSW |
2113 |
|
61-2-9889-1830 |
61-2-9889-1805 |
Keith L. Williams, CEO |
0 |
Proteome Systems is distinct from Proteome Inc., which was acquired by Incyte Genomics in December 2000. |
|||||||||
|
|
Devgen NV |
Privately held |
Technologiepark 9 |
9052 Zwijnaarde |
|
32-9-264-5402 |
32-9-264-5418 |
Theirry Bogaert, CEO and CSO |
0 |
||||||||||||
| 132. |
Eurogentec SA |
Privately held |
Parc scientifique du Sart Tilman |
Seraing |
4102 |
|
32.4.366.61.00 |
32.4.264.07.88 |
Joseph Martial, Chairman and Founder |
0 |
|||||||||||
|
|
Act Genomics Inc. |
Privately held |
6100 Royalmount Avenue |
Montréal |
Québec |
|
(514) 496-1185 |
(514) 496-9503 |
Moussa Hoummady |
0 |
|||||||||||
|
|
Active Pass Pharmaceuticals Inc. |
Privately held |
520 West 6th Avenue |
Vancouver |
BC |
|
(604) 879-2775 |
(604) 879-2707 |
Peter Reiner, Presidnet and CEO |
0 |
|||||||||||
|
|
Aegera Therapeutics Inc. |
Privately held |
810 chemin du Golf |
Ile des Soeurs |
Montreal |
Québec |
|
(514) 288-5532 |
(514) 288-9280 |
Michael Atkin, CEO |
0 |
||||||||||
|
|
BioTools Inc. |
Privately held |
800 Ironwood Professional Center |
10050 - 112 Street |
Edmonton |
Alberta |
T5K 2J1 |
|
(780) 423-1133 |
(780) 423-1333 |
Gordon Stranks, President & CEO |
0 |
|||||||||
|
|
Cytochoma Inc. |
Privately held |
116 Barrie Street |
Suite 2424Bioscience Complex Queen's University |
Kingston |
Ontario |
|
(613) 531-9995 |
(613) 531-6580 |
Robert Foldes, President and CEO |
0 |
||||||||||
|
|
Elitra Canada Ltd. |
Privately held |
225 President Kennedy Ave. W. |
Suite 2550 |
Montreal |
Québec |
|
(514) 987-4615 |
(514) 987-0389 |
Iraj Beheshti, General Manager |
0 |
||||||||||
|
|
Ellipsis Biotherapeutics Corp. |
Privately held |
70 Glengowan Road |
Toronto |
Ontario |
M4N 1G |
|
(416) 485-2185 |
(416) 489-4230 |
Jacqueline Le Saux, President |
0 |
||||||||||
|
|
Galileo Genomics Inc. |
Privately held |
880, McCaffrey |
St-Laurent |
Quebec |
H4T 2C7 |
|
514-270-3991 888.224.0388 |
514-270-4991 |
John Hooper, President and CEO |
1999 |
genepop, genefnl |
0 |
Population genetics of N Quebec Founder Population |
27aug02 |
||||||
|
|
Genechem |
Privately held |
1001, de Maisonneuve O. |
Suite 920 |
Montreal |
Quebec |
H3A 3C8 |
|
514-849-7696 |
Louis Lacasse, President |
0 |
||||||||||
|
|
GeneFocus |
Privately held |
560 Parkside Drive |
Waterloo |
ON |
N2L 5Z4 |
|
519-886-9013 |
519-886-8442 |
A. E. (Ted) Dixon, President |
0 |
Subsidiary of Biomedical Photometrics |
|||||||||
|
|
Geneka Biotechnology Inc. |
Privately held |
5445 DeLorimier |
Suite 401 |
Montreal |
Quebec |
H2H 2S5 |
|
888-343-6352 514-528-9233 |
888-528-9225 514-528-9225 |
Rino N. Camato, President and CEO |
0 |
|||||||||
|
|
GenOps Bioinformatics Inc. |
Privately held |
4259 Canada Way |
Suite 245 |
Burnaby |
BC |
V5G 1H1 |
|
(604) 451-2441 |
(604) 451-2445 |
Han Yu, Acting CEO and President |
0 |
Partially owned by PanGenomics Inc. |
||||||||
|
|
Infection Diagnostic Inc. |
Privately held |
2050 boul. Rene Levesque Ouest |
4th floor |
Sainte-Foy |
Québec |
|
(418) 681-4343 |
(418) 681-5254 |
Pierre Coulombe, President & CEO |
2 |
||||||||||
|
|
Inphogene BioCom Inc. |
Privately held |
309 - 4475 Wayburne Drive |
Burnaby |
BC |
V5G 3L1 |
|
604.453.5900 |
604.453.5910 |
Chris Carthy, President |
0 |
||||||||||
| 147. |
Integrative Proteomics Inc. |
Privately held |
100 University Avenue |
Tenth Floor (South Tower) |
Toronto |
ON |
M5J 1V6 |
|
416-645-6600 |
416-598-1262 |
John Mendlein, CEO |
0 |
|||||||||
| 148. |
Kinetek Pharmaceuticals Inc. |
Privately held |
1200 West 73rd Avenue |
Suite 850 |
Vancouver |
BC |
V6P 6G5 |
|
(604) 267-7654 |
(604) 267-7667 |
André Archimbaud, President & CEO |
0 |
|||||||||
|
|
Mirador DNA Design Inc. |
Privately held |
5252 deMaisonneuve West |
Suite 105B |
Montréal |
Québec |
|
(514) 285-2289 |
(514) 285-4969 |
Pierre Sévigny, President & CEO |
0 |
||||||||||
| 150. |
Molecular Mining Corp. |
Privately held |
128 Ontario Street |
Hamilton |
ON |
K7L 2Y4 |
|
613-547-9752 |
613-547-6835 |
Evan Steeg, President and CEO |
0 |
||||||||||
|
|
Newfound Genomics |
Privately held |
187 LeMarchant Road |
St. John's |
Newfoundland |
A1C 2H5 |
|
(709) 753 3900 |
(709) 753 1927 |
Proton Rahman, Manging Director & CSO |
0 |
||||||||||
| 152. |
PhageTech Inc. |
Privately held |
P.O. Box 387 |
Place du Parc |
Montreal |
Québec |
H2W 2N9 |
|
(514) 282-0990 |
(514) 282-9889 |
Dalal Manoli, President & CEO |
0 |
|||||||||
|
|
Phenogene Therapeutics Inc. |
Privately held |
416 de Maisonneuve West |
Suite 1020 |
Montreal |
Québec |
H3A 1L2 |
|
(514) 288-9099 |
(514) 288-1111 |
Robert Knapen, CEO |
0 |
|||||||||
| 154. |
Pro-DNA Diagnostics Inc. |
Privately held |
5345, boul. de l'Assomption |
bur.165 |
Montréal |
Québec |
|
(514) 253-9998 |
(514) 899-9669 |
Lambert Busque, Scientific Director |
0 |
||||||||||
| 155. |
ProMetic Life Sciences Inc. |
Privately held |
6100 Royalmount Avenue |
Montreal |
Quebec |
H4P 2R2 |
|
514-496-2115 |
514-496-2079 |
Pierre Laurin, President and CEO |
0 |
||||||||||
|
|
QuantaNova Canada Ltd. |
Privately held |
15 Chipman Drive |
PO Box 818 |
Kentville |
Nova Scotia |
B4N 4H8 |
|
902-678-5534 |
902-678-9440 |
Michael Winther, Presiden |
0 |
Research
arm of Scotia Holdings, |
||||||||
|
|
RabbitHutch Biotechnology Inc. |
Privately held |
Box 506 |
108 Mile Ranch |
BC |
V0K 2ZO |
|
250-791-1937 |
250-791-1938 |
0 |
|||||||||||
|
|
SeeDNABiotech Inc. |
Privately held |
P.O. Box 21082 |
Windsor |
Ontario |
|
(519) 252-8669 |
(519) 252-2915 |
Henry Heng, President |
0 |
|||||||||||
|
|
Solanum Genomics International Inc. |
Privately held |
P.O. Box # 636 |
Station A |
Fredericton |
NB |
|
(506) 444-2444 |
(506) 444-5662 |
Barry Flynn, Director of Research |
? |
agrivet |
0 |
Potato genomics |
27aug02 |
||||||
|
|
Xenon Bioresearch Inc. |
Privately held |
NRC Innovation Centre |
3250 East Mall |
Vancouver |
BC |
V6T 1W5 |
|
604-822-3995 |
604-822-4366 |
Frank Holler, President and CEO |
(0) |
|||||||||
|
|
Bios
|
Privately held |
Avenida Marathon |
1943 |
Santiago |
|
52-2-2381878 |
56-2-2394250 |
Pablo Valenzuela, CEO |
0 |
|||||||||||
|
|
Capital BioChip |
Privately held |
Jia 2# |
Qinghua West Road |
Haidian District |
Beijing |
100084 |
|
86-10-62566808 |
86-10-62566806 |
Xuenong Zhu, President and CEO |
0 |
|||||||||
|
|
E-Life Gene Medicine Co. |
Privately held |
Room 503 |
506, Royal Garden Mansion |
6 Taiping Men Stree |
Nanjing |
|
86-025-4821980 |
86-025-4821980-8012 |
0 |
|||||||||||
|
|
Shaanxi Super Science and Technology Co. Ltd. |
Privately held |
Xi'an |
|
Ru Xiaorong |
0 |
Mircoarray chip for prenatal genetic testing |
||||||||||||||
|
|
Exiqon A/S |
Privately held |
Bygstubben 9 |
Vedbaek |
DK-2950 |
|
45.45.66.08.88 |
45.45.66.18.88 |
Mikael Ørum, President and CEO |
2 |
|||||||||||
|
|
Inoxell AS |
Privately held |
6, Kogle Alle |
DK-2970 |
Horsholm |
|
45 45 16 25 25 |
45 45 16 25 00 |
Peter Kristensen, CEO |
0 |
Website
notes 4 patents issued (2 WO, 1 AU, 1 EP) and 7 pending patents (2 |
Spun out of Pharmexa A/S 30 May 2001. Pharmexa formerly M&E Biotech. |
|||||||||
|
|
ExonHit Therapeutics SA |
Privately held |
26 rue Brunel |
F-75017 |
Paris |
|
33-1-58 05 47 00 |
33-1-58 05 47 19 |
Bruno Tocque, CEO |
1998 |
Drugdev, genexpr, genefnl, phrmgen |
1 |
Cancer and neurodegen drug discovery; founded with ANVAR grant |
27aug02 |
|||||||
|
|
Gene-IT SA |
Privately held |
147, Avenue Paul Doumer |
Rueil |
malmaison |
92500 |
|
33.1.41.96.80.30 |
33.1.41.96.80.31 |
Jean-Jacques Codani, Chairman and CEO |
0 |
||||||||||
|
|
Genfit SA |
Privately held |
Parc Eurasante |
310, avenue Eugene Avinee |
59120 Loos |
|
33-03-28-55-90-60 |
33-03-28-55-90-61 |
Jean-Charles Furchart, Chairman |
0 |
|||||||||||
| 170. |
GenOdyssee SA |
Privately held |
Parc d’Affaires Technopolis |
3, avenue du Bat Alpha, PB 810 |
Courtaboef |
|
Les Ulis 91974 |
|
33-1-69-29-80-55 |
33-1-69-29-80-79 |
Jean-Louis Escary, President and CSO; Didier Lanson, CEO |
0 |
SNP and other genomics; founded with ANVAR funds |
||||||||
|
|
Genome Express |
Privately held |
11, chemin des Pres |
Meylan |
38944 |
|
33.476.88.53.74 33 (0)4 56 38 11 04 |
33 (0)4 56 38 11 09 |
Yves Laurent |
0 |
For info in US: 1610 NE Eastgate Blvd Suite 880 Pullman, WA 99163 509-332-8080 |
||||||||||
|
|
GenOway |
Privately held |
46, allee d’Italie |
69007 |
Lyon |
|
33-146-02-5800 |
33-146-02-2511 |
Alexander Fraichard, CEO |
0 |
|||||||||||
|
|
Molecular Engines Laboratories |
Privately Held |
10, rue Mercoeur |
Paris |
75011 |
|
33-1-55-25-60-63 |
33-1-55-25-60-73 |
Claude Hennion, President and CEO |
2000 |
0 |
||||||||||
|
|
UroGene SA |
Privately held |
Genopole |
4, rue Pierre Fontaine |
Evry |
91000 |
|
33.1.60.87.89.90 |
33.1.60.87.89.89 |
Christian Grenier, CEO |
0 |
||||||||||
|
|
ValiGen SA. |
Privately held |
Tour Neptune |
92086 |
Paris-La-Defense |
|
33 1 47 67 66 00 |
33 1 49 06 07 15 |
Jean-Louis Pourny, CEO |
0 |
|||||||||||
|
|
Atugen AG |
Privately held |
Robert-Rossle-Strasse 10 |
13125 |
Berlin |
|
49-30-9489-2700 |
49-30-9489-2701 |
Rudi Neirinckx, CEO, President and chairman |
0 |
|||||||||||
| 177. |
Axaron Bioscience AG |
Privately held |
Im Neuenheimer Feld 515 |
Heidelberg |
69120 |
|
49 (0) 6221 454 702 |
49 (0) 6221 454 700 |
Christopher Missling, Exec. VP |
0 |
Mainly owned by BASF and Lynx Therapeutics |
||||||||||
|
|
BioCat GmbH |
Privately held |
Im Neuenheimer Feld 581 |
Heidelberg |
D-69120 |
|
49(0)6221-5858-44 |
49(0)6221-5858-09 |
Michael Ehret and Jurgen Huber, General Managers |
0 |
|||||||||||
|
|
Biomax Informatics AG |
Privately held |
Lochhamer Straße 11 |
Martinsried |
82152 |
|
49-89-89-55-74-0 |
49 89 89-55-74-25 |
Klaus Heumann, CEO |
0 |
|||||||||||
|
|
DeveloGen AG |
Privately held |
Rudolf-Wisselstrasse 28 |
Gottingen |
D-37079 |
|
49-551-505-58512 |
49-551-505-58586 |
Guenther Karmann, CEO |
1997 |
Genefnl, genetfr |
0 |
Website notes licenses or ownership of 17 patents worldwide, but lists no patents assigned to DeveloGen |
Merger of Develogen and HepaVax Oct 2000 |
27aug02 |
||||||
|
|
Epidauros Biotechnologie AG |
Privately held |
Am Neuland 1 |
D-82347 |
Bernried |
|
49-8158-9985-0 |
49-8158-9985-48 |
Gunther Heinrich, President and CEO |
0 |
|||||||||||
|
|
Epigenomics GmbH |
Privately held |
Kastanienallee 24 |
D-10435 |
Berlin |
|
49-30-24-34-5-0 |
49-30-24-34-5-555 |
Alexander Olek, President and CEO |
0 |
|||||||||||
|
|
FeBiT GmbH (Perrarius Biotechnology) |
Privately held |
Käfertalerstrasse 190 |
Mannheim |
D-68167 |
|
49-621-3804-201 |
49-621-3804-400 |
Peer F. Staehler, CSO |
0 |
|||||||||||
|
|
Genomatix |
Privately held |
Karlstrasse 55 |
München |
Bavaria |
D-80333 |
|
49-89-54 90 83-90 49-89-54 90 83-92 |
49-89-54 90 83-99 |
Thomas Werner, CEO |
0 |
||||||||||
|
|
GenProfile AG |
Privately held |
Robert-Rossle-Straus |
D-13125 |
Berlin-Buch |
|
49-30-9489-2150 |
49-30-9489-2151 |
Margret Hoehe (Max Delbruck Center) |
0 |
|||||||||||
|
|
GPC AG (Genome Pharmaceuticals) |
Privately held |
Fraunhoferstrasse 20 |
D-82152 |
Martinsreid-Munich |
|
49-0-89-85-65-26-00 |
49-0-89-85-65-26-10 |
Bernd Seizinger, CEO |
8 |
0 for GPC but 8 for Mitotix, acquired in 2000 |
||||||||||
|
|
Graffinity Pharmaceuticals AG |
Privately held |
Im Neuenheimer Feld 518-519 |
Heidelberg |
69120 |
|
49-0-6221.649.3.0 |
49-0-6221.649.3311 |
Dirk Vetter, CEO |
0 |
|||||||||||
| 188. |
Kelman GmbH |
Privately held |
Innovationspark Wuhlheide, Haus 40 |
Koepenicker Strasse 325 |
Berlin |
D-12555 |
|
49-30-6576-3600 |
49-30-6576-3601 |
Stephan Heymann, CTO |
0 |
||||||||||
|
|
MediGene AG |
Privately held |
Lochhamer Str. 11 |
D-82152 |
Planegg-Martinsreid |
|
49-89-89-56-32-0 |
49-89-89-56-32-20 |
Peter Heinrich, CEO |
0 |
|||||||||||
|
|
MediGenomix GmbH |
Privately held |
Lochhamer Str.29 |
D-82152 |
Planegg/Martinsreid |
|
49-0-89-89-98-92-12 |
49-0-89-89-98-92-90 |
Hanns-Georg Klein |
0 |
|||||||||||
|
|
Micromet AG |
Privately held |
Am Klopferspitz 19 |
D-82152 |
Martinsried / Planegg |
|
49 (0)89 895277-0 |
49 (0)89 895277-22 |
0 |
||||||||||||
| 192. |
Morphochem AG |
Privately held |
Gmunder str. 37-37a |
Suite 116 |
Muenchen |
81379 |
|
49-0-89-78005-0 |
49-0-89-78005-555 |
Lutz Weber, CEO |
0 |
||||||||||
|
|
MWG Biotech AG |
Privately held |
Anzingerstrasse 7a |
Ebersberg |
NC |
D-85560 |
|
49-0-8092-8289-929 |
49-0-8092-8289-514 |
Matthias Schonermark, CEO WMG-Biotech Russell Golson, Head of Genomic Technology |
0 |
Joint US-German firm (survey sent to German address) |
|||||||||
|
|
U3 Pharma AG |
Privately held |
Bunsenstr.1 |
Martinsried |
D-82152 |
|
49 89 8103 90 |
49 89 8103 9199 |
Mike Rothe, CSO Axel Ullrich, Scientific Founder |
0 |
|||||||||||
|
|
WITA Proteomics AG |
Privately held |
Warthestrasse 21 |
Teltow |
D-14513 |
|
49 (0) 3328 3949 0 |
49 (0) 3328 3949 49 |
Andreas Kopke, CEO |
0 |
|||||||||||
|
|
Xantos biomedicine AG |
www.xantos-bio.de |
Privately held |
Fraunhoferstrasse, 22 |
Martinsreid |
82152 |
|
49.89.899.59.400 |
49.89.899.59.420 |
Peter Buckel, CEO |
1999 |
0 |
|||||||||
|
|
ComGenex |
Privately held |
1027 Budapest Bem rkp. 33-34 |
1388 |
Budapest |
62 |
|
36-1-214-2306 |
36-1-214-2310 |
Ferenc Darvas, President and CEO |
0 |
||||||||||
|
|
Iceland Genomics Corp. |
www.uvs.is and www.icelandgenomics.com although this second site not operating 5 Apr 01 |
Privately held |
Urour Veroandi Skuld Lynghalsi 10 |
Reykjavik |
10 |
|
354-525-3600 |
354-525-3608 |
Berhard O. Palsson, CEO |
0 |
||||||||||
|
|
Questar BioInformatics Ltd. |
Privately held (equity by Glan Pharma and other investors) |
6-3-862 Ameerpet |
Hyderabad |
500 016 |
|
91-40-340 2415/ 340 2157 |
91-40-340 2229 |
C. S. N. Murthy, CEO |
2000 |
0 |
Bioinformatics firm, incl. functional genomics |
|||||||||
|
|
Strand Genomics |
Privately held |
146, 5th Cross |
RMV Extension |
Bangalore |
560 080 |
|
91-80-3467567 |
91-80-3467568 |
Srinivasan Seshadri, CEO |
0 |
||||||||||
|
|
EiRx Therapeutics Ltd. |
Privately held |
2800 Airport Business Park |
Kinsale Road |
Cork |
|
353-021-4320847 |
353-021-4320848 |
Peter Daly, CEO |
0 |
|||||||||||
|
|
HiberGen |
Privately held |
IDA Business Park |
Bray |
County Wicklow |
|
353-1-276-9870 353-1-808-2438 CEO |
353-1-276-9888 |
Maurice N. Treacy, CEO |
0 |
|||||||||||
|
|
idGENE Pharmaceuticals Ltd. |
Privately held |
Beit Ofer, 5 Haftzrfi Street |
PO Box 34478 |
Jerusalem |
91344 |
|
972-2-659-5600 |
972-2-659-5601 |
Ariel Darvasi, President and CEO |
0 |
||||||||||
|
|
Dragon Genomics |
Privately held |
Takara Shuzo Co., Ltd. |
Biomedical Group |
Seta 3-4-1, Otsu |
Shiga |
520-2193 |
|
81-77-543-7247 |
81-77-543-9254 |
Makoto Moriguchi, President and CEO |
0 |
Parent company Takara Shuzo has 41 DPP patents |
||||||||
| 205. |
HuBit Genomix |
Privately held |
Joware Hanzoumon Building 2F |
2-19 Hayabusa-cho, Chiyoda-ku |
Tokyo |
102-0092 |
|
81-3-5212-3360 |
81-3-52123384 |
Hiromichi Kimura, CEO |
0 |
Initially Medical Genome Systems (founded April 2000) |
|||||||||
|
|
Medibic |
Privately held |
|
81-3-3280-3987 |
81-3-3280-2255 |
Yasuhiro Hashimoto, CEO |
0 |
||||||||||||||
|
|
Xanagen Inc. |
Privately held |
KSP D-1037 |
3-2-1 Sakado |
Takatsu-ku |
Kawasaki |
213-0012 |
|
81-44-829-3031 |
81-44-813-1651 |
Yutaka Ado, President |
0 |
Jointly owned by Kyowa Hakko Kogyo Co., Ltd. and Mitsui Knowledge Industry Co., Ltd. |
||||||||
|
|
Bioneer Inc. |
Privately held |
High Tech Park |
Chuckbook-Ri |
Mwee-Myon |
Cheongwon-Gun |
Chungchongbuk-Go |
|
Han-Oh Park, President and CEO |
3 |
|||||||||||
|
|
CrystalGenomics Inc. |
Privately held |
Daeduck BioCommunity |
461-6 Jeonmin-dong |
Yusung-gu |
Taejon |
305-390 |
|
82.42.866-9300 |
82.42.866-9301 |
Joong Myung Cho, President and CEO |
0 |
|||||||||
| 210. |
Genocheck |
Privately Held |
Ansan |
|
0 |
||||||||||||||||
|
|
Genomine |
Privately held |
Environmental |
University of Science and Technology Pohang |
Kyungbuk |
Pohang 226 |
790-784 |
|
Hong-Gil |
0 |
|||||||||||
|
|
MyDNA |
Privately held |
401, Inbong Building |
Yeoksam-dong |
Kangnam-gu |
Seoul |
640-21 |
|
82-2-556-1559 |
82-2-555-2598 |
Gary Song, President and CEO |
0 |
|||||||||
|
|
SuperBioChips Laboratories Inc. |
Privately held |
824-11 Yuksam-dong |
Rm 1403-2 |
Seoul |
135-934 |
|
82-2-3676-8270 |
82-2-3676-8269 |
0 |
|||||||||||
|
|
Lynk Biotechnologies Inc. |
Privately held |
41 Science Park Road |
The Gemini Building #01-21/22
|
|
117610 |
|
65 - 872-7388 |
65 - 775-9081 |
Lee Chee Wee, Acting CEO |
0 |
||||||||||
|
|
ToolGen Inc. |
Privately held |
461-6 Jeonmin-dong |
Yuseong-gu |
Taejon |
305-390 |
|
82-42-863-8166~8 |
82-42-863-3840 |
Jin-Soo Kim, President and CEO |
0 |
||||||||||
|
|
Oryzon Genomics |
Privately held |
Institute of Molecular Biology |
Barcelona |
|
Carlos Buesa, CEO |
2000 |
GENEFNL, GENEXPR |
0 |
27jul02 |
|||||||||||
|
|
Global Genomics AB |
Privately held |
Tomtebodavagen 21B |
Stockholm |
S-171 77 |
|
46.8.50.88.47.10 |
46.8.30.17.50 |
Ulf Boberg, CEO |
0 |
|||||||||||
|
|
UmanGenomics AB |
Privately held |
Umestan |
SE-903 |
Umea |
47 |
|
46-90-71-80-90 |
46-90-71-80-95 |
Sune Rosell, President |
0 |
||||||||||
|
|
Visual Bioinformatics |
Privately held |
Royal Institute of Technology |
Fiskartorpsvägen 15 A |
Stockholm |
|
46-8-676 65 60 |
46-8-676 65 69 |
Eugen Steiner, CEO |
0 |
|||||||||||
|
|
Gene Data AG |
Privately held |
Maulbeerstr. 46 |
Basel |
CH-4058 |
|
41 61 697 6099 |
41 61 697 7244 |
Othmar Pfannes, CEO |
0 |
|||||||||||
|
|
Geneva Bioinformatics |
Privately held |
25 avenue de Champel |
1206 |
Geneva |
|
41 22 702.99.00 |
41 22 702.99.99 |
Jenny Fichmann, COO |
0 |
|||||||||||
|
|
DigiGenomics Co. Ltd. |
Privately held |
8F 196 Jou-tzu Street |
Taipei |
114 |
|
886.2.265.98856 |
886.2.265.98857 |
2000 |
INFRMTX, SUPPLYR, GENEXPR, PHRMGEN |
0 |
US Pat pending, EU pat Pending |
1aug02 |
||||||||
|
|
Vita Genomics Inc. |
Privately held |
5 FL |
No. 2, Sec. 2 S. Road |
Hsin-Sheng |
Taipei |
|
886-2-8976-9123 |
886-2-8976-9523 |
Ellson Chen, President and CEO |
0 |
||||||||||
|
|
Galapagos Genomics BV |
Privately held |
BioScience Park Leiden |
Zernikedreef 6 |
2333 CL |
Leiden |
The
|
31-71-524-87-03 |
31-71-524-87-04 |
Onno van de Stolpe, Director |
0 |
Joint Belgian-Dutch firm (survey sent to Belgian address) |
|||||||||
|
|
Glaucus Proteomics BV |
Privately held |
Regulierenring 16 |
Bunnik |
Utrecht |
3981 LB |
The
|
31-30-243-3834 |
31-30-243-5764 |
Ian Humphery-Smith, COO |
0 |
||||||||||
|
|
Aneda Ltd. |
Privately held |
The Logan Building |
Roslin Biocentre |
Roslin |
Midlothian |
EH25 9PS |
|
44.131.527.4528 |
0 |
|||||||||||
| 227. |
Confirmant Ltd. |
Privately held |
Unit 66 |
The Business Development Centre |
Milton Park, Abingdon |
Oxon |
OX14 4RX |
|
44.1235..208111 |
44.1235..208020 |
Jonathan Sheldon, Chief Technology Officer |
0 |
|||||||||
|
|
DxS Ltd. |
Privately held |
Manchester Incubator Building |
48 Grafton Street |
Manchester |
M13 9XX |
|
44.161.606.7201 |
44.161.606.7313 |
Steve Little, CEO |
0 |
||||||||||
|
|
Inpharmatica Ltd. |
Privately held |
60 Charlotte Street |
London |
W1P 2AX |
|
44-0-207-631-4644 |
44-0-207-631-4844 |
Ken Powell, CEO |
0 |
|||||||||||
|
|
LGC Ltd. |
Privately held |
Queens Road |
Teddington |
Middlesex |
TW11 OLY |
|
44.20.8943.7000 |
44.20.8943.2767 |
Richard Worswick, Chief Executive |
1996 |
GENEXPR, STANDRD |
0 |
Spinoff from 150-year-old Licensed Govt Chemist |
DNA Database Laboratory started 1998; Lab-on-Chip 2001 |
31jul02 |
|||||
|
|
Microscience Ltd. |
Privately held |
Commonwealth Building |
ICSM Hammersmith Campus |
Du Cane Road |
London |
W12 0NN |
|
44-0-20-8383-3301 |
44-0-20-8383-2071 |
Rod Richards, CEO |
0 |
|||||||||
|
|
Oxagen Ltd. |
Privately held |
91 Milton Park |
Abingdon |
Oxon |
OX14 4RY |
|
44-0-1235-443300 |
44-0-1235-443301 |
Christine Soden, CFO |
0 |
||||||||||
|
|
Oxford Gene Technology |
Privately held |
BioBusiness Park |
Littlemore Park |
Oxford |
OX4 4SS |
|
44.1865.405.100 |
44.1865.405.120 |
Andrew Millar, Chief of Operations |
5 |
Licensing Southern patents and developing microarray technologies |
Founded by Edwin Southern; co-owned with Oxford Univ |
||||||||
|
|
Solexa Ltd. |
||||||||||||||||||||